Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | ATHE | ERNA | ||
| Company | Akari Therapeutics ADR | Alterity Therapeutics Ltd ADR | Eterna Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1800 | 2.48 | 1.7100 | ||
| High | 1.3512 | 2.54 | 1.8300 | ||
| Low | 1.1800 | 2.00 | 1.7000 | ||
| Last | 1.2799 | 2.19 | 1.8300 | ||
| Change | +0.0949 | -0.32 | +0.0401 | ||
| % Change | +8.01% | -12.55% | +2.24% | ||
| Volume | 22,000 | 170,800 | 6,800 | ||
| 20-Day Average Volume | 12,455 | 188,870 | 5,785 | ||
| Previous Close | 1.1850 | 2.51 | 1.7899 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.2661 | 2.16 | 2.1158 | ||
| 20-Day Raw Stochastic | 40.28% | 28.42% | 27.17% | ||
| 20-Day Relative Strength | 36.01% | 52.13% | 41.44% | ||
| Weighted Alpha | -66.31 | -53.55 | -41.59 | ||
| Today's Opinion | 88% Sell | 8% Sell | 8% Buy | ||
| Previous Opinion | 100% Sell | 24% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Sell | 56% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.47% since 04/22/24 | +3.05% since 04/22/24 | -14.49% since 04/22/24 | ||
| Low | 1.1300 on 04/23/24 | 2.00 on 04/29/24 | 1.5801 on 04/26/24 | ||
| High | 1.3512 on 04/29/24 | 2.75 on 04/26/24 | 2.2000 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -31.37% since 03/28/24 | +6.04% since 03/28/24 | -23.75% since 03/28/24 | ||
| Low | 1.0775 on 04/17/24 | 1.80 on 04/04/24 | 1.5801 on 04/26/24 | ||
| High | 1.8500 on 04/01/24 | 3.19 on 04/12/24 | 2.5000 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -52.60% since 01/29/24 | +4.52% since 01/29/24 | +9.58% since 01/29/24 | ||
| Low | 1.0775 on 04/17/24 | 1.55 on 02/23/24 | 1.4300 on 02/26/24 | ||
| High | 2.7400 on 02/02/24 | 3.19 on 04/12/24 | 2.5700 on 03/12/24 | ||
| 6-Month | |||||
| %Chg | -64.45% since 10/27/23 | -11.49% since 10/27/23 | +33.58% since 10/27/23 | ||
| Low | 1.0775 on 04/17/24 | 1.55 on 02/23/24 | 0.8401 on 12/01/23 | ||
| High | 3.7000 on 10/30/23 | 5.41 on 12/04/23 | 2.5700 on 03/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,142 | 10,252 | 9,901 | ||
| Shares Outstanding, K | 7,924 | 4,671 | 5,410 | ||
| Annual Sales | 0 | 0 | 70,000 | ||
| Annual Net Income | -10,010,000 | -9,290,000 | -21,670,000 | ||
| Last Quarter Sales | 0 | 119,159 | 20,000 | ||
| Last Quarter Net Income | -5,680,000 | -1,749,580 | -6,150,000 | ||
| 60-Month Beta | 0.96 | 0.94 | 4.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | N/A | -1.14 on 03/14/24 | ||
| Latest Earnings Date | 05/06/24 | 10/02/20 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||